• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年全国健康调查:巴西平价药房计划为高血压和糖尿病患者提供药物的情况。

National Health Survey 2019: medication obtainment through the Brazilian Popular Pharmacy Program by adults being treated for hypertension and diabetes.

机构信息

Universidade Estadual de Campinas, Departamento de Saúde Coletiva, Campinas, SP, Brasil.

Universidade de Brasília, Faculdade de Ciências da Saúde, Brasília, DF, Brasil.

出版信息

Epidemiol Serv Saude. 2022 Jul 6;31(spe1):e2021366. doi: 10.1590/SS2237-9622202200004.especial. eCollection 2022.

DOI:10.1590/SS2237-9622202200004.especial
PMID:35830016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9897825/
Abstract

OBJECTIVE

To describe the proportion of adults with hypertension and diabetes who obtained medication through the Brazilian Popular Pharmacy Program (Programa Farmácia Popular).

METHOD

Population-based descriptive study, using data from the 2019 Brazilian National Health Survey. The proportion of individuals who obtained at least one type of medication for hypertension and diabetes in the Program was analysed according to socioeconomic and demographic characteristics, by regions and federative units.

RESULTS

The proportion of individuals who obtained medication for hypertension was 45.1% (95%CI 43.7;46.5), and, for diabetes, 51.5% (95%CI 49.5;53.6). Respectively for both conditions, medication obtainment was higher in the South region (54.3%; 95%CI 51.3;57.2 and 59.1%; 95%CI 54.6;63.7) and lower in the higher strata level of education (30.9%; 95%CI 27.7;34.2 and 40.7%; 95%CI 35.1;46.3) and income (24.0%; 95%CI 19.7;28.2 and 28.9%; 95%CI 22.1;35.7).

CONCLUSION

Regional and socioeconomic inequalities were identified in obtaining medication for hypertension and diabetes through the Program.

摘要

目的

描述通过巴西平价药房计划(Programa Farmácia Popular)获得高血压和糖尿病药物的成年人比例。

方法

本研究采用基于人群的描述性研究,使用了 2019 年巴西国家卫生调查的数据。根据社会经济和人口特征,分析了通过该计划获得至少一种高血压和糖尿病药物的个体比例,按地区和联邦单位进行了分析。

结果

获得高血压药物的个体比例为 45.1%(95%置信区间:43.7-46.5),获得糖尿病药物的个体比例为 51.5%(95%置信区间:49.5-53.6)。分别针对这两种疾病,药物获取率在南部地区较高(54.3%;95%置信区间:51.3-57.2 和 59.1%;95%置信区间:54.6-63.7),在教育程度较高的阶层较低(30.9%;95%置信区间:27.7-34.2 和 40.7%;95%置信区间:35.1-46.3),以及收入水平较低(24.0%;95%置信区间:19.7-28.2 和 28.9%;95%置信区间:22.1-35.7)。

结论

通过该计划获得高血压和糖尿病药物存在地区和社会经济不平等现象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3f/9897825/d95f8aa5d3d5/2237-9622-ress-31-spe1-e2021366-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3f/9897825/9dad7fa3fe0a/2237-9622-ress-31-spe1-e2021366-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3f/9897825/d95f8aa5d3d5/2237-9622-ress-31-spe1-e2021366-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3f/9897825/9dad7fa3fe0a/2237-9622-ress-31-spe1-e2021366-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3f/9897825/d95f8aa5d3d5/2237-9622-ress-31-spe1-e2021366-gf4.jpg

相似文献

1
National Health Survey 2019: medication obtainment through the Brazilian Popular Pharmacy Program by adults being treated for hypertension and diabetes.2019 年全国健康调查:巴西平价药房计划为高血压和糖尿病患者提供药物的情况。
Epidemiol Serv Saude. 2022 Jul 6;31(spe1):e2021366. doi: 10.1590/SS2237-9622202200004.especial. eCollection 2022.
2
[Obtaining drugs for hypertension and diabetes through the Brazilian People's Pharmacy Program: results of the National Health Survey, 2013].[通过巴西人民药房计划获取高血压和糖尿病药物:2013年全国健康调查结果]
Epidemiol Serv Saude. 2016 Jan-Mar;25(1):33-44. doi: 10.5123/S1679-49742016000100004.
3
Sources of medicines for hypertension and diabetes in Brazil: results from the National Health Survey.巴西高血压和糖尿病药物的来源:全国健康调查结果
Cad Saude Publica. 2022 Oct 17;38Suppl 1(Suppl 1):e00152721. doi: 10.1590/0102-311X00152721. eCollection 2022.
4
Use of antihypertensive and antidiabetic medications in Brazil: an analysis of socioeconomic differences. National Health Survey, 2013.巴西抗高血压和抗糖尿病药物的使用情况:社会经济差异分析。2013年全国健康调查
Rev Bras Epidemiol. 2019 Oct 7;22Suppl 02(Suppl 02):E190014.SUPL.2. doi: 10.1590/1980-549720190014.supl.2. eCollection 2019.
5
[Sources of medicines for hypertension and diabetes in Brazil: telephone survey results from Brazilian state capitals and the Federal District, 2011].[巴西高血压和糖尿病药物的来源:2011年巴西各州首府和联邦区的电话调查结果]
Cad Saude Publica. 2016 Feb;32(2):e00090014. doi: 10.1590/0102-311X00090014. Epub 2016 Feb 23.
6
Sources for obtaining drugs for hypertension in Brazil: results from the National Health Survey, 2013.巴西高血压药物的获取来源:2013年全国健康调查结果
Rev Bras Epidemiol. 2015 Dec;18 Suppl 2:192-203. doi: 10.1590/1980-5497201500060017.
7
[Access to medicines for the treatment of systemic arterial hypertension and type 2 diabetes mellitus in the Brazilian population: data from the 2019 Brazilian National Health Survey].[巴西人群中用于治疗系统性动脉高血压和2型糖尿病的药物可及性:来自2019年巴西全国健康调查的数据]
Cad Saude Publica. 2024 Sep 16;40(8):e00241022. doi: 10.1590/0102-311XPT241022. eCollection 2024.
8
Impacts of a Brazilian pharmaceutical program on the health of chronic patients.巴西一项制药计划对慢性病患者健康的影响。
Rev Saude Publica. 2019 Jan 31;53:20. doi: 10.11606/S1518-8787.2019053000733.
9
Time trends in adult chronic disease inequalities by education in Brazil: 1998-2013.1998 - 2013年巴西成年人慢性病不平等状况的时间趋势:受教育程度的影响
Int J Equity Health. 2016 Nov 17;15(1):139. doi: 10.1186/s12939-016-0426-5.
10
"Inequalities in access to medicines for diabetes and hypertension across the capitals in different regions of Brazil: a population-based study".巴西不同地区首府城市糖尿病和高血压药物可及性的不平等:一项基于人群的研究
BMC Public Health. 2021 Jun 28;21(1):1242. doi: 10.1186/s12889-021-11279-6.

引用本文的文献

1
[Access to medicines for the treatment of systemic arterial hypertension and type 2 diabetes mellitus in the Brazilian population: data from the 2019 Brazilian National Health Survey].[巴西人群中用于治疗系统性动脉高血压和2型糖尿病的药物可及性:来自2019年巴西全国健康调查的数据]
Cad Saude Publica. 2024 Sep 16;40(8):e00241022. doi: 10.1590/0102-311XPT241022. eCollection 2024.
2
Epidemiology of cardiometabolic health in Latin America and strategies to address disparities.拉丁美洲心脏代谢健康的流行病学和解决差异的策略。
Nat Rev Cardiol. 2024 Dec;21(12):849-864. doi: 10.1038/s41569-024-01058-2. Epub 2024 Jul 25.
3

本文引用的文献

1
Tendency of use and sources for obtaining oral antidiabetic drugs for treatment of diabetes in Brazil from 2012 to 2018: analysis of the Vigitel survey.2012 年至 2018 年巴西用于治疗糖尿病的口服抗糖尿病药物的使用趋势和来源:Vigitel 调查分析。
Rev Bras Epidemiol. 2021 Jan 6;24:e210008. doi: 10.1590/1980-549720210008. eCollection 2021.
2
National Health Survey 2019: history, methods and perspectives.2019 年全国健康调查:历史、方法和展望。
Epidemiol Serv Saude. 2020 Oct 5;29(5):e2020315. doi: 10.1590/S1679-49742020000500004. eCollection 2020.
3
Prevalence of use and sources of antihypertensive medicine in Brazil: an analysis of the VIGITEL telephone survey.
Cardiovascular Statistics - Brazil 2023.
心血管统计数据 - 巴西2023年
Arq Bras Cardiol. 2024 Feb;121(2):e20240079. doi: 10.36660/abc.20240079.
4
2019 National Health Survey: progress in monitoring the health of the Brazilian people.2019年全国健康调查:巴西人民健康监测进展
Epidemiol Serv Saude. 2022 Aug 8;31(spe1):e2021309. doi: 10.1590/SS2237-9622202200001.especial.
巴西抗高血压药物的使用 prevalence 及来源:基于 VIGITEL 电话调查的分析
Rev Bras Epidemiol. 2020;23:e200028. doi: 10.1590/1980-549720200028. Epub 2020 May 11.
4
The Brazilian health system at crossroads: progress, crisis and resilience.处于十字路口的巴西卫生系统:进步、危机与韧性。
BMJ Glob Health. 2018 Jul 3;3(4):e000829. doi: 10.1136/bmjgh-2018-000829. eCollection 2018.
5
Brazil's Unified Health System and the National Health Promotion Policy: prospects, results, progress and challenges in times of crisis.巴西统一卫生系统与国家健康促进政策:危机时期的前景、成果、进展与挑战
Cien Saude Colet. 2018 Jun;23(6):1799-1809. doi: 10.1590/1413-81232018236.04782018.
6
[Sources of medicines for chronic patients using the Brazilian Unified National Health System].[使用巴西统一国家卫生系统的慢性病患者的药品来源]
Cad Saude Publica. 2018 Mar 26;34(3):e00073817. doi: 10.1590/0102-311X00073817.
7
Progress with the Strategic Action Plan for Tackling Chronic Non-Communicable Diseases in Brazil, 2011-2015.《2011 - 2015年巴西应对慢性非传染性疾病战略行动计划》进展情况
Epidemiol Serv Saude. 2016 Apr-Jun;25(2):373-390. doi: 10.5123/S1679-49742016000200016.
8
[Obtaining drugs for hypertension and diabetes through the Brazilian People's Pharmacy Program: results of the National Health Survey, 2013].[通过巴西人民药房计划获取高血压和糖尿病药物:2013年全国健康调查结果]
Epidemiol Serv Saude. 2016 Jan-Mar;25(1):33-44. doi: 10.5123/S1679-49742016000100004.
9
Surveillance and monitoring of major chronic diseases in Brazil - National Health Survey, 2013.巴西主要慢性病的监测与监控——2013年全国健康调查
Rev Bras Epidemiol. 2015 Dec;18 Suppl 2:3-16. doi: 10.1590/1980-5497201500060002.
10
Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil.大众药房计划:巴西药品补贴政策实施十年间药品地理可及性的变化
J Pharm Policy Pract. 2015 Mar 9;8(1):10. doi: 10.1186/s40545-015-0030-x. eCollection 2015.